Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenjing Huayu Zhitong is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of primary dysmenorrhea. Its name reflects its therapeutic principles in TCM: "Wenjing" (warming the meridians), "Huayu" (resolving blood stasis), and "Zhitong" (relieving pain). The formula is primarily investigated for its ability to modulate endocrine and immune mechanisms, specifically targeting the regulation of prostaglandins (such as PGF2α and PGE2) and cytokines involved in uterine contraction and pain signaling. Clinical and preclinical studies conducted by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine have explored its immediate analgesic effects compared to standard treatments like ibuprofen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenjing Huayu Zhitong.